NEW SHUTTLE VAN EXPANDS SERVICES TO FAMILIES IN NEED
DETROIT, Oct. 11, 2023 /PRNewswire/ -- Ronald McDonald House Charities Detroit (RMHC Detroit) is celebrating the arrival of their newly purchased ADA Compliant, 12 passenger shuttle van with a ribbon cutting and celebration ceremony at two locations on Thursday, October 19th.
As part of their "Love Drives Us" capital campaign and program expansion plans the shuttle van is the catalyst that will allow RMHC Detroit to serve more hospitals in the Detroit community providing a House and hospitality programs to the families of ill or injured children.
In the last 45 years RMHC Detroit has given nearly 20,000 families a place to call home. CEO Jennifer Litomisky says, "this van opens the doors to support more families for years to come!"
Date: October 19th, 2023 Location(s) & Time: Ribbon Cutting Ceremony - 10am LaFontaine Chevrolet Buick GMC St. Clair 3050 King Rd., China Township MI 48054
Welcome Home Ceremony - 11:30am - 1pm Ronald McDonald House Charities Detroit 4707 St. Antoine St., Suite 200 Detroit, MI 48201
Medical imaging IT and cybersecurity company Sectra (STO: SECT B) is publishing its Annual Report and Sustainability Report for the 2023/2024 fiscal year today. This report also includes the Corporate Governance Report for the same period.
The...
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...
